Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial-Reference-Cited by-同舟云学术

Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial

Published:2022-07-27 Issue:1 Volume:11 Page:1833-1842
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Sánchez Barrueco Álvaro¹²^ORCID,Mateos-Moreno María Victoria³^ORCID,Martínez-Beneyto Yolanda⁴⁵^ORCID,García-Vázquez Elisa⁶,Campos González Alfonso¹^ORCID,Zapardiel Ferrero Javier⁷⁸,Bogoya Castaño Abel¹,Alcalá Rueda Ignacio²^ORCID,Villacampa Aubá José Miguel¹^ORCID,Cenjor Español Carlos¹,Moreno-Parrado Laura⁹,Ausina-Márquez Verónica¹⁰,García-Esteban Sandra¹¹,Artacho Alejandro¹¹,López-Labrador F. Xavier¹¹¹²¹³^ORCID,Mira Alex¹¹¹³^ORCID,Ferrer María D.¹¹^ORCID

Affiliation:

1. ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain

2. ENT and Cervicofacial Surgery Department, Villalba General University Hospital, Collado Villalba, Spain

3. Department of Dental Clinical Specialties, School of Dentistry, Madrid Complutense University, Madrid, Spain

4. Department of Dermatology, Stomatology and Radiology, University of Murcia, Murcia, Spain

5. Murcian Institute of Biosanitary Research (IMIB), Murcia, Spain

6. Infectious Diseases Unit, Virgen de la Arrixaca University Clinical Hospital, IMIB, Murcia, Spain

7. Microbiology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain

8. Villalba General University Hospital, Collado Villalba, Spain

9. Microbiology Service, Murcian Institute of Biosanitary Research, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain

10. Department of Dentistry, European University of Valencia, Valencia, Spain

11. Genomics & Health Department, FISABIO-Public Health Foundation, Valencia, Spain

12. Department of Microbiology and Ecology, Medical School, University of Valencia, Valencia, Spain

13. CIBER in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain

Funder

Consellería de Sanitat Universal i Salut Pública

European Fund of Regional Development / European Social Fund

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2098059

Reference38 articles.

1. Worldometer. Coronavirus Cases. 2022; [cited May 27 2022]. Available from: https://www.worldometers.info/coronavirus/.

2. COVID-19: a fast evolving pandemic

3. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

4. Consistent Detection of 2019 Novel Coronavirus in Saliva

5. The role of mouthwash sampling in SARS-CoV-2 diagnosis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study;PeerJ;2023-12-18

2. Eligibility and efficacy of a CPC‐ and CHX‐based antiviral mouthwash for the elimination of SARS‐CoV‐2 from the saliva: A randomized, double‐blind, controlled clinical trial;Journal of Clinical Periodontology;2023-12-07

3. Efficacy of different mouthwashes against COVID-19: A systematic review and network meta-analysis;Japanese Dental Science Review;2023-12

4. Mouthwash Effects on the Oral Microbiome: Are They Good, Bad, or Balanced?;International Dental Journal;2023-11

5. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis;BMC Infectious Diseases;2023-10-11